Institutional investors purchased a net $5.9 million shares of MDCO during the quarter ended December 2013 and now own 106.65% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
POINTSTATE CAPITAL LP Bought 3.8 Million shares of Medicines Co
CREATIVE PLANNING, INC. Bought 6.0 Thousand shares of Medicines Co
SPIDERROCK TRADING LLC Bought 500.00 shares of Medicines Co